Company / Revenue
NEPHROS INC Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$18.8M
FY2025
5-year range
$10.0M / $18.8M
FY2021-FY2025
Trend
+32.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $2M in FY2017 to $19M in FY2025.
Based on SEC 10-K filings.
$19M in FY2025 with a 5-year CAGR of +17.0%.
Improved from $10M to $19M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +23.5%
- 5-Year CAGR
- +17.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +17.0%, indicating consistent growth.
- In FY2025, revenue increased 32.0% year-over-year.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -5.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $18.8M | +32.0% |
| FY2024 | $14.2M | +42.7% |
| FY2023 | $10.0M | +0.0% |
| FY2022 | $10.0M | -2.4% |
| FY2021 | $10.2M | +19.3% |
| FY2020 | $8.6M | -17.2% |
| FY2019 | $10.3M | +81.7% |
| FY2018 | $5.7M | +145.1% |
| FY2017 | $2.3M | +0.0% |
| FY2016 | $2.3M | +19.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026